Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Levi Fried

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Pigment Cell & Melanoma Research|April 4, 2008
The reactive oxygen-driven tumor: relevance to melanomaLevi Fried, Jack L Arbiser
Lymphatic Research and Biology|March 29, 2008
Mammalian target of rapamycin (mTOR) is activated in cutaneous vascular malformations in vivoFarheen Shirazi, Cynthia Cohen, Levi Fried, et al.
Journal of the American Academy of Dermatology|March 18, 2008
Targeted therapy of oral hairy leukoplakia with gentian violetSulochana S Bhandarkar, Jamie MacKelfresh, Levi Fried, et al.
Lymphatic Research and Biology|October 28, 2008
Efficacy of rapamycin in scleroderma: a case studyLevi Fried, Robert S Kirsner, Sulochana Bhandarkar, et al.
Cell Cycle (Georgetown, Tex.)|September 27, 2013
Identifying new small molecule anti-invasive compounds for glioma treatmentJennifer Munson, Michael Bonner, Levi Fried, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2008
Tris (dibenzylideneacetone) dipalladium, a N-myristoyltransferase-1 inhibitor, is effective against melanoma growth in vitro and in vivoSulochana S Bhandarkar, Jacqueline Bromberg, Carol Carrillo, et al.
Plos One|January 24, 2013
Triphenylmethane derivatives have high in vitro and in vivo activity against the main causative agents of cutaneous leishmaniasisRenata Celi Carvalho de Souza Pietra, Lucas Fonseca Rodrigues, Eliane Teixeira, et al.
Cancer Research|May 22, 2009
Secreted frizzle-related protein 2 stimulates angiogenesis via a calcineurin/NFAT signaling pathwayAndrew Courtwright, Sharareh Siamakpour-Reihani, Jack L Arbiser, et al.
Science Translational Medicine|March 31, 2012
Anti-invasive adjuvant therapy with imipramine blue enhances chemotherapeutic efficacy against gliomaJennifer M Munson, Levi Fried, Sydney A Rowson, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Pigment Cell & Melanoma Research|April 4, 2008
The reactive oxygen-driven tumor: relevance to melanomaLevi Fried, Jack L Arbiser
Lymphatic Research and Biology|March 29, 2008
Mammalian target of rapamycin (mTOR) is activated in cutaneous vascular malformations in vivoFarheen Shirazi, Cynthia Cohen, Levi Fried, et al.
Journal of the American Academy of Dermatology|March 18, 2008
Targeted therapy of oral hairy leukoplakia with gentian violetSulochana S Bhandarkar, Jamie MacKelfresh, Levi Fried, et al.
Lymphatic Research and Biology|October 28, 2008
Efficacy of rapamycin in scleroderma: a case studyLevi Fried, Robert S Kirsner, Sulochana Bhandarkar, et al.
Cell Cycle (Georgetown, Tex.)|September 27, 2013
Identifying new small molecule anti-invasive compounds for glioma treatmentJennifer Munson, Michael Bonner, Levi Fried, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2008
Tris (dibenzylideneacetone) dipalladium, a N-myristoyltransferase-1 inhibitor, is effective against melanoma growth in vitro and in vivoSulochana S Bhandarkar, Jacqueline Bromberg, Carol Carrillo, et al.
Plos One|January 24, 2013
Triphenylmethane derivatives have high in vitro and in vivo activity against the main causative agents of cutaneous leishmaniasisRenata Celi Carvalho de Souza Pietra, Lucas Fonseca Rodrigues, Eliane Teixeira, et al.
Cancer Research|May 22, 2009
Secreted frizzle-related protein 2 stimulates angiogenesis via a calcineurin/NFAT signaling pathwayAndrew Courtwright, Sharareh Siamakpour-Reihani, Jack L Arbiser, et al.
Science Translational Medicine|March 31, 2012
Anti-invasive adjuvant therapy with imipramine blue enhances chemotherapeutic efficacy against gliomaJennifer M Munson, Levi Fried, Sydney A Rowson, et al.
Pageof 1